BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32154989)

  • 1. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
    Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
    Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
    Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
    J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Utility of Whole Exome Sequencing in the Neuromuscular Clinic.
    Waldrop MA; Pastore M; Schrader R; Sites E; Bartholomew D; Tsao CY; Flanigan KM
    Neuropediatrics; 2019 Apr; 50(2):96-102. PubMed ID: 30665247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.
    Fattahi Z; Kalhor Z; Fadaee M; Vazehan R; Parsimehr E; Abolhassani A; Beheshtian M; Zamani G; Nafissi S; Nilipour Y; Akbari MR; Kahrizi K; Kariminejad A; Najmabadi H
    Clin Genet; 2017 Mar; 91(3):386-402. PubMed ID: 27234031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approach.
    Krenn M; Tomschik M; Rath J; Cetin H; Grisold A; Zulehner G; Milenkovic I; Stogmann E; Zimprich A; Strom TM; Meitinger T; Wagner M; Zimprich F
    Eur J Neurol; 2020 Jan; 27(1):51-61. PubMed ID: 31407473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of exome sequencing for the diagnosis of pediatric-onset neuromuscular diseases beyond diagnostic yield: a narrative review.
    Piñeros-Fernández MC; Morte B; García-Giménez JL
    Neurol Sci; 2024 Apr; 45(4):1455-1464. PubMed ID: 37989827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Challenges of Neuromuscular Disorders after Whole Exome Sequencing.
    Chen PS; Chao CC; Tsai LK; Huang HY; Chien YH; Huang PH; Hwu WL; Hsieh ST; Lee NC; Hsueh HW; Yang CC
    J Neuromuscul Dis; 2023; 10(4):667-684. PubMed ID: 37066920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation.
    Headrick AT; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Penny DJ; Kim JJ; Landstrom AP
    Mol Genet Genomic Med; 2019 Jun; 7(6):e593. PubMed ID: 30985088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
    Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
    Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise.
    Landstrom AP; Fernandez E; Rosenfeld JA; Yang Y; Dailey-Schwartz AL; Miyake CY; Allen HD; Penny DJ; Kim JJ
    Heart Rhythm; 2018 Jul; 15(7):1042-1050. PubMed ID: 29501670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease.
    Herman I; Lopez MA; Marafi D; Pehlivan D; Calame DG; Abid F; Lotze TE
    Muscle Nerve; 2021 Mar; 63(3):304-310. PubMed ID: 33146414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
    Marchant RG; Bryen SJ; Bahlo M; Cairns A; Chao KR; Corbett A; Davis MR; Ganesh VS; Ghaoui R; Jones KJ; Kornberg AJ; Lek M; Liang C; MacArthur DG; Oates EC; O'Donnell-Luria A; O'Grady GL; Osei-Owusu IA; Rafehi H; Reddel SW; Roxburgh RH; Ryan MM; Sandaradura SA; Scott LW; Valkanas E; Weisburd B; Young H; Evesson FJ; Waddell LB; Cooper ST
    Ann Clin Transl Neurol; 2024 May; 11(5):1250-1266. PubMed ID: 38544359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability.
    Snoeijen-Schouwenaars FM; van Ool JS; Verhoeven JS; van Mierlo P; Braakman HMH; Smeets EE; Nicolai J; Schoots J; Teunissen MWA; Rouhl RPW; Tan IY; Yntema HG; Brunner HG; Pfundt R; Stegmann AP; Kamsteeg EJ; Schelhaas HJ; Willemsen MH
    Epilepsia; 2019 Jan; 60(1):155-164. PubMed ID: 30525188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
    Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
    Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of whole-exome sequencing results in neurogenetic diseases.
    Balasar Ö; Başdemirci M
    J Hum Genet; 2023 Dec; 68(12):797-804. PubMed ID: 37524782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiered analysis of whole-exome sequencing for epilepsy diagnosis.
    Dunn PJ; Maher BH; Albury CL; Stuart S; Sutherland HG; Maksemous N; Benton MC; Smith RA; Haupt LM; Griffiths LR
    Mol Genet Genomics; 2020 May; 295(3):751-763. PubMed ID: 32146541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the Genetic Testing of Neuromuscular Diseases.
    Shieh PB
    Neurol Clin; 2020 Aug; 38(3):519-528. PubMed ID: 32703465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing.
    Hiraide T; Yamoto K; Masunaga Y; Asahina M; Endoh Y; Ohkubo Y; Matsubayashi T; Tsurui S; Yamada H; Yanagi K; Nakashima M; Hirano K; Sugimura H; Fukuda T; Ogata T; Saitsu H
    Clin Genet; 2021 Jul; 100(1):40-50. PubMed ID: 33644862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.